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CLINICAL STUDIES
Early Revascularization Improves Survival in Cardiogenic Shock
Complicating Acute Myocardial Infarction
ALI R . MOOSVI, MD, FAREED KHAJA, MD, FACC, LUIS VILLANUEVA, MD,
MIHAI GHEORGIIIADE, MD, FACC, LORI DOUTH .AT, RN, SIDNEY GOLDSTEIN, MD, FACC
!arrow, Michigan
The entcts of coronary ravaseularization by percutamans trans-
tuminal coronary angioplasty or coronary bypass grafting, or
both, an survival were evaluated in 81 patients with eardiogenic
shock complicating acute myocardial infarction . Thirty-two pa-
tients had successful reyaaculxrizalien and 49 patients had unsuc-
cessful or no revaeularizalion . Revasrlarrzaliun was achieved by
aagoutasty in 22 petunia, curunarr byessssurgery in 2
and angioplasty followed by bypass surgery In K No significant
differences were noted between the two grmps with
m8-rd
to
baseline clinical or hemodynamle variables. mtraaorlk ba9oan
counterpulsation was employed in 27 (84%) of the 32 patients in
the group with revasculariration and in 19 (39%) of the 49
patients without revascularizetion (p = 0 .0006).
The in-hospital survival was significantly better in the patients
with-18 (56%) of 32-than in the patients without revascular-
tzation-4 (8%) of 49 (p < 0,0801). At a neon follow-up period of
Cardiogenie shock complicating acute myocardial infarction
continues to have a very high mortality cot :, that in some
series before 1980 exceeded 80% 11-6i .'rhe use of inotropic
and vasopressor agents in the management of cordiogenie
shock did not result in any survival benefits 17-1 5 ) . Although
intraaortic balloon counterpulsation helped to stabilize these
patients, it failed to improve survival (16,17) . Intravenous
thrombolytic agents improved survival in patients with acute
myocardial infarction (18-21), but not in those whose infarc-
lion was complicated by severe congestive heart failure
(Killip class 4) (18) . A modest survival benefit was reported
when patients with cardiogenic shock were treated with
intracoranary streptokinase (22).
The use of surgical and mechanical interventions in
patients with severe left ventricular dysfunction has been
examined to determine if there are any benefits of ressoring
blood flow to ischemic areas of the myocardium . It was
found (23) that urgent introduction of intraaorlic balloon
eounterpulsatinn followed by coronary bypass surgery may
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mantas, tMsservlvatd~ereneepersested-1615h4c) of 32
patients with reratxolxizatiaa survived versus 1 (204 or 49
patients without revascniariratba
(p
< 0A4t!t. Tile mean time
from the onset of shale to reasrahmatiau differed si niacaatly
between survivors (12,4 w 151s) arm nansvavtvnrs (58,5 w 93 h) in
the group with rerascplarimtian Ip = 0.ooo4) .
In the rerJUCwlac-
iaation g
group, the in-hospital survival rate w&, 77% 117 of 22)
when -secularization was paefermed within 24 h hot only 10%
1 of 101 when it was perfoewrd after 24 b ip= 10MI-
These data suggest that the comhhmtlnn of snccesslal coronary
revascularization and brbaaortk balloon pumping is ess9ciated
with improved survival in patients with cardiogenic shock con.
plicating acute myocardial infarction . This improvemee( in sur-
vival is most evident if revastvlarization is performed forty,
partice!arly within 24 h of the onset of cardiogenie shorn .
(j Am Colt Csrdiot fy92 ;19:907-14)
improve survive( in shock . Successful reperfusion with
thrombolytic therapy or coronary angioplasty also appeared
to have survival benefits in patients with cardiogenie shock
(24-261. The survival in surgical series with predominuelly
nananechanieol causes of shock has varied from 40% to 887
123,27-331 . We reviewed our 5-year experience in the man-
agement of patients with tardiogenic shock complicating
acute myocardial infarctiuu to examine the factors that
influcacc survival .
Methods
Selection of patients. The records of all patients admitted
to Henry Ford Hospital from memory 1987 to May 1990 with
the diagnosis of cardiugunie shock cumplicating acute myo-
cardial infarction were retrospectively examined . These
patients were identified by a prospcct
.cly collected data
base of the cardiology intensive care unit and were cross-
checked with the cardiac calheterization laboratory aagio-
plaety registry data
. Myocardial infarction was characterized
by I) chest discomfort consistent with myocardial ischurnia ;
2) electrocardiogram IECO) demonstrating S - r segment ele-
vation at mm or new Q waves in two consecutive Icnds
; and
3) elevation of total creatine kinase (CK) (>200 lWiter) and
its mH fraction (>390).
073t .1097.'922.t .00
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P.eSauion of cardiogenic shock . There were five criteria :
I) arterial systolic blood pressure <80 mm
Hg without
inotropic and or intraaortic balloon pump support : 2) arterial
systolic blood pressure <90 mm Hg with inotropic support ;
3) absence of h ypovolemia. as demonstrated by pulmonary
capillary wedge Pressure >12 mm Hg :, 4) cardiu - index <2
.2
liters/min per mc; and 5) clinical evidence of hypoperfusion
(obtundation, oliguria, cold and clammy extremities) .
Patient inctusion
criteria.
Apar from the clinical criteria,
patients had to satisfy all four hemedynaruic criteria of shock
for inclusion in the study . Pulmonary artery catheterization
was performed in all patients and hemodynamic data were
recorded when cardiogenic shock was diagnosed . Patients
who did out have hemodynamic criteria as described and
those whose hemodynnmic data could not be obtained were
nut included in this study.
Study patients . Eighty-three consecutive patients with
cardiogenic shuck were identified . Two patients with ven-
tricular septa) rupture managed by surgical repair of the
septum were excluded . One patient in shock with severe left
ventricular dysfunction and initial regurgitation required
mitr'al valve replacement in addition to coronary bypass
surgery and is included in the study
. The remaining 81
patients were classified into groups with and without revas-
cularization as judged by the success of revascularization by
percutaneous coronary angioplasty or coronary artery by-
pass grafting, or both .
Definition of revascularization
. Successful revasculariza-
lion with angioplasty was defined as restoration of adequate
(Thrombolysis in Myocardial Infarction ITIMI) grade 2 or 3)
blood flow to the infarct-related artery and a residual steno-
sis <50% at the completion of the procedure . Revascular-
ization with bypass surgery was considered successful when
the infarct-related artery was grafted . The duration of time
from the symptomatic onset of myocardial infarction in the
development of cardiogenic shock and from shuck tv revas-
cularization'was documented in hours .
Decision far intervention . 'The decision to send a patient
for coronary angiography and placement of an intraaortic
balloon pump was made at the discretion of the patient's
cardiologist . Therefore, patients received these procedures
in a nonrandomized manner depending on their cardiolo-
gist's personal preference . The decision to perform coronary
angioplasty was made by the interventional cardiologist in
conjunction with the patient's cardiologist based on the
coronary anatomy as defined by the angiogram . Percutane-
ous Iransluminal coronary angioplasty was attempted only
on the infarct-related artery . No attempt was made to
provide complete revascularization in the patient in the
initial setting. Angioplasty was performed with use of stan-
dard guiding catheters, steerable wire and balloon systems.
The pmicnts were followed up during their subsequent
routine visits to the clinic or by telephone . The long-term
follow-up was complete in 80 (99%) of the 81 patients .
Statistical analysis. All numerical results are eupecssed as
mean values and SD
. The Wilcoxon rank sum test was used
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for testing numeric study variables . Categoric variables were
tested by the t,c-taiied Fisher exact test whenever two
categories were involved and the general chi-square test of
association was used for more than two categories
. To
reduce the risk of type I error, a p value <0 .01 was
considered significant . Results with p values of 0.01 to 0 .05
were considered borderline significant. Cumulative survival
was calculated by the Kaplan-Meier survival analysis
method . Differences
between survival curves were analyzed
by the log rank method . Multivariate Cox regression analysis
wns used to determine the significance of variables that were
borderline significant .
kesults
Study group (Table 1). During the study period from
January 1985 to May 1990, 1,346 patients with confirmed
acute myocardial infarction were admitted to the coronary
care unit ; 81 (6%) with eardiogenic shock constituted the
study population . The group with revascularization con-
sisted of 32 parents in whom successful revascularization
was achieved by coronary angioplasty in 22 patients, bypass
surgery in 2 and angioplasty followed by bypass surgery in 8,
only I of whom had unsuccessful angioplasty. The group
without revascularization consisted of 49 patients, of whom
41 had conventional medical therapy and 8 had an unsuc-
cessful angioplasty . Of these eight patients, one died in the
cathelcrizatiotl laboratory and the other seven had coronary
anatomy that was unsuitable for bypass surgery .
There were no differences in the groups with and without
revascularization with respect to age, gender, previous his-
tory of diabetes mellitus, congestive heart failure or coro-
nary bypass grafting. History of prior myocardial infarction
was more common in the patients without revascularization,
achieving borderline significance (p = 0.05) . The patients'
medications before admission were not significantly different
in the two groups
. The location of the acute myocardial
infarction that caused cardiogenic shock was similar in both
groups. The two groups were compared for in-hospital
events or complications that might adversely affect mortality
from the date of admission to the date of discharge or
in-hospital death. Ventricular fibrillation was more frequent
in patients without revascularization and was a common
terminal event . There were no differences within the two
groups with regard to peak creatine kinase, percent MB
fraction of crentine kinase, blood urea nitrogen and serum
creatinine .
Balloon pump and ihrombolysis. Intraaortic balloon
pump support was employed in 27 (84%) of 32 patients in the
group with revascularization and in 19 (39%) of the 49
patients in the group withoul revascularization (p < 0 .0006).
Intravenous thrombolytic t:- rapy was utilized in 8 (25%) of
the 32 patients with revascularizatiun ; 4 (50%) of these
patients were discharged alive. It was also used in 5 ( 10%)
of the 49 patients who were not revascalarized with no
survivors .
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Ikmodynamics (Table 2). Hemodynamic data obtained m
the onset of cardiogenic shock were similar in both groups,
Among the patients whose ejection fraction was obtained by
catheterization or by noninvasive tr .chniques, the mean
ejection fraction was 30.9% in the group with revaseulariza-
lion and 25 .3% in the group without revascularization (p =
0
.044 [borderline significance]) .
Survival (Table 3) . Of the total group of 81 patients, 22
(27%p) were discharged alive and 16 (20%) were alive after 21
15 months of follow up. The in-hospital survival rate was
significantly better in patients with revascularization (56% ;
18 of 32) than in those without revascularization
(8% ; 4 of 49)
(p < 0
.0001) (Fig
. 1) . At a mean follow-up of 21 ± 15 months
this survival difference persisted-16 (50%) of 32 patients in
the group with rauascularization survived compared with 1
(2%) of the 49 without revascularization (p < 0
.1001) One
patient without revascularization was lost to follow-up and is
reported in this study as the presumed sole survivor of that
NCGSVI Ei AL.
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*Borderline sgninem.l. `Significant . Unless
otherwise Indicated . data are eeprcsued as number and percent
of
patients wither without nevaxulan¢anon ECU - Hedracmdmgmpnn.
999
group at follow-up . The in-hospital survival cane (Fig . 2)
aemonstratee that decrease in survival occurs early during
the hospital stay .
Fort— inflorncing survival in rhegmup with revascolar-
(ra2ian are shown in Table 3. A significant difference ob-
served between survivors and eonsutvivors in this grcup
was the time from development of cardiogenic shock to
revascularization . The mean time from development of
shock to revascularization in survivors was 12 .4
1
15 h
compared with 58.5 ± 93 h in nonsurvivors (p = 0.004)
(Fig .
3) . The in-hospital survival rate in patients with revascular-
ization was 77% (17 of 22) when revascularization was
performed within 24 h compared with 10%
(t of 10) when it
was performed after 24h (p = 0.0006) (Fig . 4) . At a follow-up
interval of 21
1
. 15 months, 15 (68%1 of the 22
patients who
underwent revaserrlasization within 24 h ets. 'ived compared
with 1 (10%) of the 10 patients in whom revascularization
was performed after 24 h .
Table t . Clinical Data in RI Parkenus
With
Rcvusculorisauon
rn -
32,
Without
Revasnllarisunn
In - 49,
p
S ilue
Age (yrl Iran 2 SD) 64
-
la 67 a 10 0 .17
Male 191sr51 -6(7 e1 os2
Precious medical history
Heart failure "Ib'kl 11(27%) 0.17
Myocaldiei tnfardinn
S~ 1759)1 24140 0.05'
Coronary bypass grafting ?169x)
3(6901 0 .99
Diabetes mellitus ID t31'hl 16 (330%1 1 .0
Medications before admission
Nitrates 22160 33167%) L0
Beta-blockers 712201 16 03%) 0.33
Calcium channel blockers 7122%I tO(30%) 0.22
Digitalis 4(I3`•z l 918%1 x55
Diuretics 121387.1 27153%) 017
ECG
location of infarct
Anleriorilmeral 16(11031 3r (63%)
026
Inferior/posterior 161503) 141two 0 .1
Left bundle branch Mock 0 4(891 0 .14
Supportive therapy
Inotrupic support 3919401 46 (9401 0.99
Intubation 30f94%I 42(86%) 3.24
Intravenous thrombolync agent S RS111 5116%) 0.12
Intraaonic balloon pump 27(04(0) 19139%) 0.11605'
Inhospitalevenrs
Poslinfarelioa angim 10 (317
.
.1 0 51601 017
Recurrent myocardial infarction d113") 6)129) 1 .0
Ventricular
tachycardia 13141 %) 1715593) 426
Ssslnsuhrftbrillaf n 912e%) 2613301
0 .04
•
line From infarction to shack Ih) fmean _ SDI 58 e R3 %=S1 0.67
Time from shock to ¢vasculari~tion 01Inenn m Sm 33_16 0
Laboratory data
maximal values)
Tornl creature kin., elUgik,) Ul's 2.164 0.1
CraDine kin- M8 Lacrian (IL) 2110 03 U 116
Bland area nitrogen In01109 tall
11
53 011
Creetinine (m8/t@0 rnb 1 33 Oda
91o MU05VI ET AL.
REVASCULARIZATION IN CARDIOGENIC SHOCK
'Ejection Fraction available in 30 patiems with and 33 palienls without revasculnrizalion
. tl3nrderl ine significant,
Icaroaary angiogmphy was petfmared in 32 patients with and 23 palienls
without
revascullrixmion. Values are
nxprrssed as mean values I SD or ac number and pecan or patients with or without mvascularlralian
.
Discussion
Cardiogenic
shock complicating acute myocardial infarc •
don
. This study esnmined the factors that influence survival
in patients with cardiogenic shock complicating myocardial
infarction. Our
data suggest that coronary revascularizatiuu
achieved by percutaneous transluntinal
coronary angioplasty
or surgical coronary bypass grafring combined with iniraaor-
tic balloor, counlerpulsation improves survival . This im-
provemeni in survival is most evident if
the revasculatiza-
Tahle 3
. Characteristics of Patients With Successful Revasculerizalion
lion is performed early, particularly within 24 h of
the onset
of cardiogcnic shock.
Cardiogenic shock occurs in 546 to 15% of patients who
develop acute myocardial inforction (1-4) . This condition
continues to have a very high mortality rate that in some
series is >80 (1-5)
. Killip et al, (h) reported that, despite a
reduction in overall mortality from myocardial infarction
after the advent of intensive care units, only 19% of patients
with shock survived, Conventional medical therapy with rose
'Ejection fraction was available in I7 survivors and 13 e,11 .1vrvors . (Significant
. Untusv nlherwise relicated •
data me expressed as number and rercem of survivors nr nnnsmivors .
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Iable 2, Hemndynamic and A.Siographic Data in 81 Pelienls
w.iablr
With
Revasculuri'ealiun
In-32)
Without
Revswu105111nioa
(n=49)
p
Value
Hcarlratclbeatdrain)
he
	
14
109
20
0,11
Systolic blond pressure (loot Hg) 81 * 8 93 4 13
032
Right atria) pressure Imm Hg) 14 -- 6 13 t 6
09
Pulmonaryenelysystatie 41 * 12 44 * ii
0,27
prosai (mnt Hgi
Pulmonary capillary wedge
23 ! 6 25 * 7 0,16
presure (um Hg)
Cardiac indea (liters!min per eu) 1 .6- 0.4
0.15
1 .8 x 0 .5
Eje<tionfraction (S3" 30 .9± 12 25.3 * 9 0,0449
Coronary angiograph5t
1-Vesscl d'uease
11 (34971 3 (1343) 0.12
2-Vesse)doense
12(38951 1114897) 058
3-Vesaddi'azee
511591 0126%) 050
Leh main disease 441371) 1411%) 099
Survivors
(n=18)
Nonsarvivors
as =14)
p
Value
Age YO
C.... ! S17) 63 * 10 65 s 9 0.82
Previous infarction (3)
5(28) 31211 1 .0
©iabets tuellilus (%1 5 (16)
51101 0.71
Hose failure ( 7 2 (6) 0
0.50
Myocsrdlul infernlon 1461 5 (16)
316) 1 .0
Anterior infarction (9) 11(61)
57361 0.28
Systolic blood pressure Imm Hg) 82±7
81 * 9 0.83
Pulmonary capillary wedge
P'- . . Imm Hg)
22 ± 7
13 * 5 0.34
Cardiac index (litemrmin per m'1
1 .8 s 0.a 1 .8 ! 0.5 0.38
Ejeehon haaien 4%)
32 a 13 30 ! 11 0.78
Mulriuesselwmaerydiseasel%I
121677 8(171
Imrauortic balloon pomp %I
161891 11(79) 0.57
lntubation 191
161891 1411001 1
.0
Anutnmicellycnmplch
revascalarizati0n 1%I
9887 9 ;361
0.46
Time from shack to
revasculorizetien 1h)
!mean ±SDI
12 .4 * 15
58 a 93 5.000+
MA6'C V
.0 19, Nn 5
ApH 12+1'007
-In
too
9 :
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Figure 1. Influence of revascularization on in hospital and long-term
survival in 81 patients with cardioeeme shock complicating acute
myocardial infarction . Hatched bars = patients with revasculaocn-
tion; solid bars = patients without revascularizationr
of adrenergic
. vasoactive and inotropic agents has failed to
improve survival in cardiogenic shock (7-15 .35).
Use of intraaortic balloon pump . Intraaurtic balloon
counterpulsation in patients with cardiogenic shock fre-
quently improves hemodynnmic status without affecting
survival (16,17). A recent preliminary report (361 suggested
that patients treated with the intraaortic balloon had better
survival than those who did not have balloon collnterptdsa-
tion. However, in that report 67% of patients who received
balloon counterpulsation also underwent coronary revascu-
larization compared with 5% of patients in the group that
was not managed with balloon counterpulsation. Therefore,
from that study (36) it appears that a strategy of balloon
counterpulsation and revascularization, rather than balloon
counterpulsation alone . improves survival
. These data sup-
port the conclusions we have reached in the present study .
Thrombolysis in shock . Although intravenous throm-
bolytic agents have been shown to decrease mortality from
myocardial infarction, patients with Kitlip chess IV conger-
Figure 2 . Comparison of in-hospital cumulative survival in 32 pa-
tients with (trimlates)
p.sd 49 patlrets wilhual (e:udes)
revasculariza-
tion At 42 days there were 18 surviving parents (56i%) in the group
with revasculaization and 4 (8"dl in the group without rovescular-
-nation.
WOW] FT M 911
.ioc aCL LMIILAIIO9 IN CAFOWCENIC 9vCIClt
00
Z
to 4
on= ran (n--141
Fag,-3. Compunsunolthe time Iron asset of cardingeoic shock to
revaseuianzatian in 18 survivors and 14 nonsurvivos in the group
with revascularization .
ti- heart failure in the Gruppo Italiano per to Studio
della Streptochinasi nell'infarto Miocardieo (GISSI) trial
had a survival rate of about 30% in both streptokinase- and
placebo-treated groups (18-21) . When intracoronary strep-
tokinase was used in patients with cardiogenic shock, Ken-
nedy et al . (22) reported a survival rate of 58%a in patients
with successful reperfusion compared with 16% survival
among those with unsuccessful reperfusion. It should be
noted that intracoronary streptokinase in this study was
successful in producing repetfusion in only 43% of the
patients with shock .
Coronary angioplasty in shock. Studies (37 .39) have dem-
onstrated the feasibility and acceptable risk associated with
coronary angioplasty in acute myocardial infarction and the
fact that it can achieve reperfusion rates from 78% to 90% .
Lee et of (24) compared survival in 24 patients undergoing
coronary angioplasty for cardiogenic shock between 1982
and 1985, with survival in 59 patients treated conventionally
during 1975 to 1982
. The 3D-day
survival rate in patientswith
successful reperfusion was 77% versus 17% in convention-
ally treated patients. However, in their study the historical
central subjects had been treated during a
different time
period . In the Duke Registry (25) . patstts with shock had a
survival rate of 71% when reperfusion was successful and
Figure 4. Beneficial effscr an in-hospital and long-term (21
7
15
m,'nths) ;arvival when tevascularization was pe4nrmed within 24 h
(hatched bars) versus >24 h (solid ham) after me asset of shock .
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35% when it was unsuccessful . In this Registry successful
reperfusion was achieved by thrombolytic therapy in 22
patients (53%), by angioplasty in 17 patients (40%) and by
bypass surgery in 3 patients (7l) .
Garrahy eL al . (39) analyzed dale tiom the TIM!-2 study
and concluded that the efficacy of angioplasty after throm-
bolytic therapy in cardiogenic shock was uncertain . This
conclusion was based on the k-week survival rates of 33%
and 31%, respectively, in patients with and without at-
tempted angiopiasty . However, angioplasty was attempted
in only 18 (12%) of the 148 patients and was successful in I I
(61%l of the 13. Therefore, given this small group of II
patients undergoing successful angioplasty, drurite conclu-
sions cannot be drawn regardin
; the efficacy of this proce-
dure .
Surgery in shock. In surgical series (23,27-33) that pre-
dominantly included aonmechanical causes of shock, revas-
cularization resulted in reported rates of survival varying
from 40o to 88% . Fouling data from these nine surgical
series indicates a survival rate
0f57%(11i)0f
192) among the
patients who underwent coronary bypass surgery .
Survival with revascularization in shock . In our study the
in-hospital survival was significantly better in patients with
than in those without revascularization. The major criticism
of our study is that 1) it is a retrospective, nonrandomized
analysis, and 2) it is possible that a selection bias existed for
the patients with revascularization that contributed to im-
proved survival in this group . Because the incidence of
shock is low at our center, we would need a long period of
time to accumulate enough patients to conduct a prospective
randomized trial . Alsn, nor ongoing experience with coro-
nary angioplasty indicated that it could be performed safely
in patients with acute infarction . Because the groups with
and without revascularization in our study appeared to be
baianced with regard to baseline characteristics and hero-
dynamic variables, with same exceptions of borderline sig-
nificance, it appears that all patients analyzed were at high
risk (Table 1). Apart from revascularization and the we of
the intraarriic balloon pump, management strategies were
similar in both groups, However, revascularization was the
only variable that contributed significantly toward survival .
One of the important results from this study was the
excellent long-term survival in patients with revasculariza-
tion . Of the 18 such patients, 16 (89%) were alive at a mean
follow-up interval of 21 *- IS months, compared with only 1
(25%) of the patients without revascularization who were
discharged . Lee et al . 140) is a recent multicenter study of
angioplasty in shock also reported a significantly better
survival rate at 24 months of 545) in patients with successful
reperfusion compared with 11% in patients with unsuccess-
ful reperfusion. Revascularization, in fact, may have its
greatest effect on long-tetra survival.
Timing of intervention in shock. The time interval from
shock to revascularization is an important factor affecting
survival
. Survival is significantly better when revascutariza'
JACC vat, 19. Nv. 5
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tioa is performed early after the onset of shock . DeWood et
al . (23) showed that early surgical revascularization along
with I traaortic balloon counterpulsation improved survival
in cardiogenic shock. The Survival of patients who under-
went reperfusion and imraaortic balloon counrerpulsarion
within 16 h from the onset of symptoms of myocardial
infarction was 75% compared with 29% if these interventions
were performed after If h . Data from the Mayo Clinic (26)
also suggest that early successfitt angioplasty decreases
mortality. All 45 patients in that study were treated with
angioplasty performed within 24 h of acute myocardial
hsfarclion complicated by cardiogenic shock . The in-hospital
survival rate in the patients with successful angioplasty was
71% compared with 29% in patients whose angioplasty was
unsuccessful . These data support our finding that early
revascularizatiun improves survival in patients with cardio-
genic shock .
Possible mechanisms of benefits from revascularizatfon
in
shock. It is unclear why revascularization that is "early"
with regard to the development of cardiogenic shock but
"late" with regard to occlusion of the coronary artery
should produce any benefit . Page et al. (41) studied 20
patients with shock and found all patients exhibited necrosis
of a4O% of the loll ventricular myocardium. Patients who
die as a consequence of shock usually have "piecemeal" and
progressive necrosis of the myocardium with extension of
the infarct to an ischemic zone bordering the infarct area (42)
and an associated persistent elevation of serum enzyme
levels (43). It has been shown (44-48) that infarct expansion
and left ventricular dilation can occur after acute occlusion
and myocardial damage- The ventricular dilation usually
occurs early but may progress during the next few months
(47,48) . Infarct expansion and left ventricular dilation are
associated with hemodynamic deterioration, left ventricular
rupture and an increase in mortality (49-52) . Animal exper-
iments (53) have demonstrated that late reperfusioa after
coronary artery ligation does not reduce infarr size but
limits infarct expansion . It is possible that revascularization
in cardiogenic shock limits such progressive myocardial
necrosis, protects the surrounding pert-infarct zone and
prevents infarct expansion, Also, deterioration of multiple
organ systems in prolonged shock can affect survival ad-
versely. Data from the Multicenter Investigation of Limita-
tion of Infarct Size (MILLS) study (34) indicate that the
independent predictors of developing shock in patients with
acute myocardial infarction were age >65 years, left ventric-
ular ejection fraction <359h on admission, peak CK MB
> 1601Ulliter and a history of diabetes mellitus and previous
myocardial infarction. It may be desirable to identify such
subsets of patients who are at high risk of developing shock
and perform a study to observe whether revascularization
prevents the development of cardiogenic shock .
Conclusions. Despite the methodologic limitations, our
data suggest that successful coronary revascularization
with coronary angioplasty or bypass surgery is associated
with improved short- and long-term survival in patients with
JACC Vat. 19 . No. 4
April 1992:907-14
cardiogenic shock . This improvement in survival is most
evident if nevasculaization is performed early, particularly
within 24 h of the onset of cardmv
,
iiie shack .
We thank Linda JaSnn for her help in the preparation of,lms,ameecript .
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